The CSF represents the transcellular fluid of relevance in the central nervous system and both Trx1 and Grx1 are increased in the CSF of early-stage AD patients and correlated with standard AD biomarkers such as tau and phosphor-tau [109]. The gene discussed is MAPT; the disease is Alzheimer disease.